Standard Family Office’s Idexx Laboratories IDXX Stock Holding History

Standard Family Office’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-19	Closed	-$6K	–	208
2022 Q3	$6K	Hold	19	–	–	﹤0.01%	290
2022 Q2	$7K	Sell	19 -236	-93%	-$96.2K	0.07%	113
2022 Q1	$140K	Buy	255 +250	+5,000%	+$132K	0.04%	23
2021 Q4	$3K	Buy	+5	New	+$3.14K	0.03%	168
2021 Q3	–	Sell	-35	Closed	-$22K	–	287
2021 Q2	$22K	Hold	35	–	–	﹤0.01%	236
2021 Q1	$17K	Buy	35 +9	+35%	+$4.51K	﹤0.01%	299
2020 Q4	$13K	Buy	+26	New	+$11.6K	﹤0.01%	300

Other funds holding IDXX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $13.6B AUM 7.6% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Standard Family Office's IDXX Position: Q4 2022 in Review

Standard Family Office sold out of Idexx Laboratories (IDXX) in Q4 2022, closing a stake of 19 shares — an estimated $6K sold.

Standard Family Office first reported a position in IDXX in Q4 2020 and held it in 7 quarters. The position peaked at $140K in Q1 2022. 999 funds tracked by Wall St. Rank hold IDXX as of Q4 2022.

Standard Family Office reported no remaining Idexx Laboratories position as of Q4 2022 after selling out during the quarter.
Standard Family Office sold 19 Idexx Laboratories shares in Q4 2022, an estimated $6K.
Standard Family Office first reported a position in Idexx Laboratories in Q4 2020 and held it in 7 quarters.
Standard Family Office's Idexx Laboratories position peaked at $140K in Q1 2022.
999 funds tracked by Wall St. Rank held Idexx Laboratories as of Q4 2022.

Based on Standard Family Office's 13F filing for Q4 2022, filed 13 Feb 2023.